Biotech financing

Data exhibit index
Page
8
9
10
10
11
12
13
14
15
16
17
17
18
19
20
21
22
23
24
25
Figurentents
Innovation capital in the US and Europe surpassed US$40 billion in 2015
US and European early-stage venture investment reached unprecedented heights
More than 30% of all US and European venture investment came via seed and first rounds
US and European biotechnology IPO pricing by year
US and European biotechnology IPOs by year
US biotechnology financings by year
Innovation capital in the US by year
US venture capital skyrocketed above US$9 billion in 2015
Innovation capital raised by leading US regions, 2015
Top US venture financings, 2015
US biotechnology IPOs by year
US biotechnology IPO pricing by quarter, 2013–15
Top US biotech IPOs, 2015
European biotechnology financings by year
European innovation capital by year
Innovation capital raised by leading European countries, 2015
European venture capital by year
Top European venture financing, 2015
European biotechnology IPOs by year
Top European biotech IPOs, 2015
Beyond borders 2016 — Biotech financing
29